It should be the discretion of individual physicians, not insurance companies or pharmacies, to substitute a branded biologic for a biosimilar, which goes back to putting the physician in the decision making process, not the non clinical analyzers. While the search for "cheap" continues...
Personalized Medicine and Genomics are getting some serious attention, why, because it will save money and hopefully better healthcare in the process. The days when your DNA will determine what drug your physician will prescribe may not be too far off. Developers and researchers are...